Impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria (mHealth-Cervix): Protocol for a randomised controlled trial
| Autor: | Jonathan S. Berek, Olusanjo E Moses, Muisi A Adenekan, Kehinde S Okunade, Bassey Ebenso, Rose I Anorlu, Adebola A Adejimi, Matthew J Allsop, Omolola Salako, Oluwatosin J Akinsola, Omolara Fatiregun |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
mHealth-Cervix medicine.medical_specialty 020205 medical informatics Uterine Cervical Neoplasms Nigeria 02 engineering and technology General Biochemistry Genetics and Molecular Biology law.invention 03 medical and health sciences Study Protocol 0302 clinical medicine Randomized controlled trial law 0202 electrical engineering electronic engineering information engineering medicine Outpatient clinic Humans Multicenter Studies as Topic 030212 general & internal medicine Pap test General Pharmacology Toxicology and Pharmaceutics NHIS mHealth Cervix Early Detection of Cancer Aged Randomized Controlled Trials as Topic Cervical cancer General Immunology and Microbiology medicine.diagnostic_test business.industry Lagos Reproducibility of Results General Medicine Articles Middle Aged medicine.disease Telemedicine Exact test Health promotion medicine.anatomical_structure Family medicine Female business |
| Zdroj: | F1000Research |
| ISSN: | 2046-1402 |
| Popis: | Background:Incidence and mortality from cervical cancer have remained high due to many obstacles facing the implementation of organized screening programs in resource-constrained countries such as Nigeria. The application of mobile technologies (mHealth) to health services delivery has the potential to reduce inequalities, empower patients to control their health, and improve the cost-effectiveness of health care delivery.Aim:To assess the efficacy of mobile technology intervention on Pap test screening adherence compared to a control condition and also determine the factors affecting the uptake of Pap smear screening practices among women in Lagos.Methods:This is a multi-center randomized controlled trial that will involve women aged 25 to 65 years attending the General Outpatient clinics of the two tertiary health institutions in Lagos, Nigeria between April and December 2020. At baseline, a total of 200 National Health Insurance Scheme (NHIS) enrollees will be randomized to either a text message arm or usual care (control) arm. The primary outcome is the completion of a Pap smear within 6 months of enrolment in the study. The associations between any two groups of continuous variables will be tested using the independent sample t-test (normal distribution) or the Mann-Whitney U test (skewed data) and that of two groups of categorical variables with Chi-squareX2or Fisher's exact test where appropriate. Using binary logistic regression model, we will adjust for age and other relevant sociodemographic and clinical variables and adherence to Pap test screening. Statistical significance will be defined asP-value less than 0.05.Discussion:The mHealth-Cervix study will evaluate the impact of mobile technologies on cervical cancer screening practices in Lagos, Nigeria as a way of contributing to the reduction in the wide disparities in cervical cancer incidence through early detection facilitated using health promotion to improve Pap smear screening adherence.Registration:PACTR20200275335451713/02/2020 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|